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INTRODUCTION 
 
Investigating proteins ‘at work’ in a living environment at atomic resolution is a major goal 
of molecular biology, which has not been achieved even though methods for the three-
dimensional structure determination of purified proteins in single crystals or in solution are 
widely used. Various intracellular events such as conformational changes, dynamics and 
binding events have been investigated by this method. The detailed analysis of the network 
of interactions between proteins within a cell is a key step to understand the mechanisms 
that are located at the base of numerous pathologies. 
Through the use of high-resolution spectroscopic techniques such as NMR and X-ray 
crystallography has been possible to obtain important information about protein structures 
and their function. The problem is that such techniques allow us to study a protein in non-
physiological conditions, outside of the intracellular environment in which a protein is 
naturally found. 
Until a short time ago the only way to be able to study an intracellular event consisted of 
marking the molecules of interest (for example with fluorescent probes such as GFP), and 
subsequently following the intracellular fate through the use of microscopic techniques 
such as fluorescence microscopy. 
Such techniques have a low resolution and allow to obtain information only on a general 
intracellular event, preventing from obtaining the molecular details of what happens within 
a cell. 
Using advanced methods of molecular biology, cellular biology and NMR, it was possible 
to obtain multidimensional heteronuclear NMR spectra of macromolecules in vivo at high 
resolution, both in prokaryotes and in eukaryotes
[1]
. In this way it was possible to analyze 
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in detail a number of intracellular events such as conformational changes and dynamic 
binding events between biological molecules
[2]
. 
“In-cell NMR” experiments do not aim at determining structures directly in the cellular 
environment, but use the sensitivity of the chemical shift towards changes in the 
environment to obtain information about the state of a macromolecule in its natural 
surroundings. Changes in this environment, caused by post-translational modifications, 
conformational changes, or binding events, result in changes in the resonance frequencies 
of the affected nuclei and can thus be detected by “in-cell NMR” experiments. The 
investigation and characterization of macromolecules in living cells by NMR spectroscopy 
has to overcome three main difficulties
[3]
. First, the NMR signals of the molecule of 
interest must be distinguished from the NMR resonances of all other cellular components. 
Second, the macromolecule must be able to tumble freely, and third the cells have to 
survive the conditions inside the NMR tube at least for the time period of the experiment 
without significant changes of their metabolic state. Distinguishing the NMR resonances of 
a macromolecule from all other resonances of the cell can be achieved by overexpressing 
the macromolecule and labeling with the NMR-active isotopes 
15
N and 
13
C. 
A major limitation for the application of high-resolution liquid state NMR spectroscopy of 
biological macromolecules is the requirement that these molecules have to tumble in 
solution with a sufficiently short correlation time. Long rotational correlation times lead to 
fast relaxation and, therefore, broad peaks. Since the rotational correlation time is 
proportional to the surrounding viscosity, the intracellular viscosity is an important 
parameter for the observation of macromolecules inside living cells
[3]
. Diffusion 
measurements have indeed shown that the translational diffusion of a macromolecule 
inside cells can be severely restricted relative to an in vitro system with the purified 
molecule. The intracellular rotational correlation time is only twice as long as the rotational 
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correlation time of the same molecule in pure water. This increase by a factor of two of the 
rotational correlation time also increases the apparent molecular weight of the protein by a 
factor of two. Fortunately, the recent introduction of TROSY
[4]
and similar techniques
[5][6]
 
has extended the applicability of NMR spectroscopy to large macromolecules with a 
molecular weight of 100 kDa and more. These technical advances, combined with the 
relatively low viscosity of the cellular cytoplasm, predict that the cytoplasmic viscosity is 
not a major limitation for the observation of proteins inside living cells.  
The third critical parameter that strongly influences the applicability of in-cell NMR 
experiments is the survival rate of the cells in the NMR tube. In particular, the high cellular 
density can cause problems through oxygen starvation and limiting the amount of available 
nutrients. If the sensitivity of the selected system (mainly the overexpression level) is high 
enough, the NMR spectra can be measured relatively quickly (less than an hour)
[3]
. 
Thanks to the application of more and more faster experiments (FAST-NMR)
[7]
and use of 
high amounts of labeled proteins of interest, these problems have been exceeded. In fact by 
“in cell NMR” 3D protein structure was calculated exclusively on the basis of information 
obtained in living cells
[8] 
(Fig. 1). 
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The structure of the putative heavy-metal binding protein TTHA1718 from Thermus 
thermophilus HB8 over-expressed in Escherichia coli cells was solved by in-cell NMR. 
Rapid measurement of the 3D NMR spectra by nonlinear sampling of the indirectly 
acquired dimensions was used to overcome problems caused by the instability and low 
sensitivity of living E. coli samples. Almost all of the expected backbone NMR resonances 
and most of the side-chain NMR resonances were observed and assigned with high quality. 
Structures calculated are very similar to the in vitro structure of TTHA1718 determined 
independently. The in-cell NMR approach can thus provide accurate high-resolution 
structures of proteins in living environments
[8]
.  
To demonstrate the broad application of this technique, the in-cell NMR can be used to  
Fig. 1NMR solution structure of TTHA1718 in living E. coli cells. Prokaryotic in-cell NMR approaches 
typically employ recombinant protein over-expression, isotope labeling and in-cell NMR analyses within the 
same cell type. Suspensions of bacterial cells are directly analyzed without purification of the recombinant 
protein. A superposition of the 20 final structures of THA1718 in living E. coli cells, showing the backbone 
(N, C, C’) atoms [8]. 
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studying interactions and protein processing. For example, in-cell NMR spectroscopy 
demonstrates that both ubiquitin and its mutant 3A have much higher hydrogen exchange 
rates in the intracellular environment, possibly due to multiple interactions with 
endogenous proteins
[9]
 (Fig. 2). In addition, the same technique can also be applied to 
studying protein interactions with small compounds, such as screening drugs targeted to 
specific proteins.  
 
 
Indeed, the in-cell NMR spectra of FKBP12 (also known as FKBP1A) show the formation 
of specific complexes between the protein and extracellularly administered 
immunosuppressants, demonstrating the utility of this technique in drug screening 
programs
[9]
. 
Fig. 2 The hydrogen exchange rates in eukaryotic cells. Eukaryotic in-cell NMR applications can 
involve isotope labeling in bacterial cells and recombinant protein purification prior to in-cell NMR 
sample preparation. Labeled proteins are then transferred into eukaryotic cells by microinjection, or 
other vector-based transduction techniques. The hydrogen exchange rates (kex) in cells and in vitro at pH 
7.4 of protected amides in wild type ubiquitin and in the mutant 3A 
[9]
. 
 INTRODUCTION 
 
6 
 
This technique can be also used to study post-translational protein modifications (PTMs) 
that occur in living environments such as phosphorylation and acetylation
[10]
 or 
methylation
[11] 
that regulate a large number of eukaryotic signaling processes.  
At the same time comparable results between analyses performed on whole live cells and 
extracts have been obtained (Fig. 3). 
 
In a recent paper of Selenko et al.
[12]
 it was demonstrated the experimental feasibility of 
high resolution NMR measurements in the complex environments of crude Xenopus egg 
extracts. These extracts are especially suited to predict the cellular behavior of a protein in 
a conveniently accessible, homogenous solution that closely resembles the cytoplasmic 
properties of intact cells. Extract NMR measurements may be used to indicate the 
likelihood for satisfactory in-cell NMR experiments and/or may serve to independently 
analyze structural and functional aspects of biological activities of a protein in a cell-free 
setting. Because extracts are easily prepared in large quantities and because most 
biological reactions are executed with comparable activities in these ex vivo mixtures, we 
wish to strongly emphasize their supplementary potential for ‘‘cellular’’ NMR analyses. 
Moreover, these extracts can be selectively depleted of individual cellular components or 
supplemented with recombinant proteins, small molecule inhibitors, and other components, 
allowing NMR analyses under defined cellular conditions
[12]
.  
Fig.3 Overview of the preparation of extract NMR samples. 
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Over the years various approaches have been developed for the transfer of macromolecules 
in animal and plant cells; among these methods, cationic liposomes are able to transfer 
molecules penetrating into the cell by fusion with the plasma membrane. 
Despite numerous systems have been developed to transfer the macromolecules into living 
cells, they have a number of limitations that preclude its routine use in in vivo studies, in 
particular for possible therapeutic applications in the clinical field. The main obstacles are 
summarized in the low efficiency of internalization, in the complexity of handling, in the 
application of expensive equipment, in the difficulty of release into the cytosol and 
sometimes in cellular toxicity and immunogenicity. 
To facilitate the internalization of proteins of interest into the cells it has been developed a 
technology that involves the conjugation of the protein with small peptides (10-15 amino 
acid residues) characterized by the presence of numerous basic amino acids, such as 
arginine. Using molecular biology techniques it is possible to fuse such peptides to the 
nucleotide sequence of a specific protein to facilitate the entry into the cell. 
Furthermore, there are numerous agents, such as pyrenebutyrate, capable of favoring the 
passage of the cellular membrane and the entry into the target cell
[13]
. 
Cell compartmentalization and impermeability of membranes represent the major obstacle 
for the delivery of therapeutic molecules; in fact, many bioactive molecules are incapable 
of overcoming the membrane permeability barrier and this represents the major 
impediment for gene and drug targeting in theranostics. Although a wide variety of bio-
drugs, including peptides and proteins, are now produced on a commercial scale, one 
challenging task for pharmaceutical researchers is devise ways to deliver these drugs 
effectively and safely via non-invasive, patient-friendly routes
[14][15]
. 
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Cell-penetrating peptides (CPPs) are a valuable class of natural short peptide sequences 
which have been recently considered very promising for cellular uptake and membrane 
interaction studies
[16] 
(Fig. 4). 
 
 
Fig. 4 Different molecules can be transported into the cell by the CPP. 
 
While individual CPPs differ in length and sequence, they share some common features, 
which include their amphipathic nature, net positive charge, hydrophobicity and helical 
moment, the ability to interact with lipidic membranes and to adopt a distinct secondary 
structure upon association with lipids
[17]
. These short cationic peptides either by covalent 
or noncovalent binding have been exploited for the delivery of a range of macromolecules 
in the biologically active form such as proteins, plasmids, siRNA, nanoparticles, PNAs, 
and liposomes, that are otherwise impermeable to the plasma membrane. Unfortunately, 
CPPs application in cellular delivery has been hampered by the controversy regarding their 
uptake mechanism; in fact, no defined picture of the mechanism has jet emerged
[16-20]
. 
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Among the CPPs, the human immunodeficiency virus type 1 (HIV-1) TAT basic domain  
has been used extensively for macromolecule delivery
[20-22]
. TAT is a nuclear 
transcriptional activator protein consisting of 101 amino acids. This protein is required for 
viral replication by HIV-1. The truncated sequence of HIV-1 TAT 49–57 (RKKRRQRRR) 
is a highly basic region typically involved in cellular translocation
[20]
 and proteins as small 
as GFPs (30 kDa) and as large as IgG (150 kDa) have been delivered efficiently by TAT 
peptide
[23]
. Problems in the application of CPPs arise from the unfavorable 
physicochemical and biological properties of therapeutic peptides and proteins to deliver, 
which may affect their absorption. In fact, the use of a charged delivery peptide may 
represent a disadvantage in some cases. Therefore, it is fundamental to exploit novel 
molecules which present different structural characteristics and use different internalization 
mechanisms
[24]
. For this reason, great attention has been recently devoted to the study of 
hydrophobic peptides that efficiently traverse biological membranes, promoting lipid 
membrane-reorganizing processes, such as fusion or pore formation and thus involving 
temporary membrane destabilization and subsequent reorganization
[25]
. Viral derived 
peptides, in particular those derived from viral entry proteins, may be useful as delivery 
vehicles due to their intrinsic properties of inducing membrane perturbation
[26-28]
. Delivery 
across cellular membranes involves several mechanisms such as direct transfer through cell 
surface membrane by lipid membrane fusion or transient permeabilization of the cell 
membrane or, after endocytosis, transfer across vesicular membranes by lipid disruption, 
pore formation or fusion.  
The nineteen residues peptide gH625 was previously identified as a membrane-perturbing 
domain in the gH protein of Herpes simplex virus type I (Fig. 5); gH625 interacts with 
model membranes, contributing to their merging; it is able to traverse the membrane 
bilayer and to transport a cargo into the cytoplasm and across the blood brain barrier
[25-29]
. 
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In particular, it’s reported the ability of gH625 peptide to transport quantum dots inside the 
cytoplasm in an efficient way and only partially involving endocytic pathways
[30]
, 
moreover it’s reported its ability to enhance intracellular penetration of liposomes 
functionalized with the peptide on the external leaflet
[31]
, nanoparticles
[15] 
and 
dendrimers
[14]
. Compared to the TAT peptide which mainly exploits the endocytic 
pathway, the viral membranotropic peptide gH625 crosses membrane bilayers mainly 
through a translocation mechanism. 
 
 
Fig.5 Representation of the region  of Herpes Simplex virus type 1 in which the peptide gh625-644 has been 
identified. In red the aromatic residues of peptide. 
 
The hydrophobicity of gH625 compared to the positively charged TAT can represent an 
advantage for the delivery of an acidic and natively unfolded protein such as the C-
terminal domain of the protein h-prune.  
H-prune is the best characterized interactor of Nm23-H1. Its mRNA and protein expression 
is high in advanced neuroblastoma (NBL), combined with high protein levels in serum
[32]
, 
which indicates that it has a function as a metastasis-promoter gene in NBL.  
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Indeed, amplification and over-expression of Nm23-H1, and also of the S120G mutation of 
Nm23-H1 (Nm23-H1-S120G) have been detected in 14% to 30% of patients with 
advanced NBL stages. The Nm23-H1 mechanism in the mediation of NBL aggressiveness 
remains to be understood and it is still subject to debate. In this mechanism the complex 
Nm23-H1/h-prune is involved, so it is very important to understand the molecular basis of 
this interaction. The h-prune protein is a member of the phosphoesterases (DHH) protein 
superfamily, and its overexpression in breast, colorectal and gastric cancers correlates with 
the level of invasion and the degree of lymph-node and distant metastases
[33-36] 
(Fig.6).  
 
 
 
H-prune also has a phosphodiesterase (cAMP-PDE) activity, and inhibition of this PDE 
activity with dipyridamole suppresses cell motility in breast cancer cell lines
[37-39]
. The N-
terminus of the h-prune sequence contains the DHH (amino acids 10-180) and DHHA2 
(amino acids 215-360) domains that are involved in its enzymatic function. Of note, there 
Fig.6 Model of the activation of h-prune and its protein-interactor functions that result in a high motility 
phenotype, thus leading to substantial changes in cell status: from a primary to a metastatic cancer cell 
environment. 
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is an additional function of h-prune within this N-terminus that includes the DHH domains: 
an exopolyphosphatase (PPASE) activity that was described by Lahti and colleagues 
through its homology similarities with the yeast protein
[40]
. However, this additional 
activity does not affect either the cell motility of breast cancer cell lines or their metastasis 
formation in vivo
[41]
.  
These domains are then followed by a cortexillin-homology region (CDH, amino acids 
360-453) that contains putative coiled-coil and proline-rich regions. The C-terminal region 
of h-prune (amino acids 353-454, c-prune) (Fig.7) is responsible for its interaction with 
GSK-3β [42] and with Nm23-H1[43].  
 
 
The Nm23-H1/h-prune interaction is mediated through casein kinase (CKI, CKII) 
phosphorylation of Ser120, Ser122 and Ser125 of Nm23-H1
[44]
, phosphorylation sites that 
have been highly conserved through evolution, and that promote enhanced cell 
motility
[45][46]
. The conformational analysis of the c-prune performed by NMR showed that 
it assumes a random coil conformation with the exception of some protein regions with 
helical structural propensity and a disulphuric bridge as unique rigid linkage defining it an 
intrinsically disordered domain (IDD). In addition the recombinant c-prune was sufficient  
Fig. 7 The h-prune C-terminal sequence. The amino acids given in bold represent those that are more exposed 
according to limited proteolysis experiments. 
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to bind the characterized interacting Nm23-H1 endogenous protein as verified by western 
blotting analysis and NMR spectroscopy
[41]
. C-prune is stable and soluble. His sequence 
has a low overall hydrophobicity and a high net negative charge, and analyses according to 
several algorithms have suggested that it is mostly unfolded in the native protein. The 
1
H 
NMR spectra of c-prune have been very difficult to assign due to poor dispersion of the 
resonances. To increase the dispersion of the NMR signals and to allow analysis of the 
dynamics using multinuclear NMR spectroscopy, uniformly 
15
N-labeled and 
15
N/
13
C-
labeled c-prune samples were prepared. Sequential assignments of the 
1
HN, 
15
N, 
13
CO, 
13
C, 1H and 
13
C resonances were obtained in full following a standard triple-resonance 
procedure. A 
1
H-
15
N hetero-nuclear single quantum coherence (HSQC) spectrum of c-
prune is shown in Fig.8. The chemical shift assignments allowed an analysis of the 
secondary structure of the protein by comparison with random coil values corrected for 
local sequence effects. As shown in Fig.9, multinuclear (H C, C, C’) chemical shift 
indexing (CSI) plots suggest that the majority of the resonances of c-prune are within the 
random coil range. Nevertheless, the CSI values of the amino-acid sequences from Leu355 
to Ser365 (1 helical region), from Glu381 to Asp388 (2 helical region), and from 
Leu428 to Gln439 (3 helical region) are consistent with an -helical secondary structure 
propensity. The CSI data are also supported by the 
3
JHNHA coupling-constant 
measurements, which are characteristic of unfolded molecules, with the exception of the 
three helical regions, which have means of 5.3 Hz, as typical of helical structures
[41]
. A 
three-dimensional model of the full-length h-prune protein was then built using an N-
terminal (amino acids 1-352) h-prune structure derived by homology modelling and 
attached to a representative NMR c-prune structure. The full-length h-prune model was 
then refined through molecular dynamics simulation in vacuo. The analysis of the whole  
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structure indicates that the N terminus (amino acids 353-370) of c-prune (Fig.10A) is 
indeed part of the h-prune DHH2 domain, and in particular constitutes the second part of 
the last helix and a turned region that interacts with the preceding helix; accordingly, this 
region in c-prune has a clear helical propensity (Fig. 9). Therefore, the IDD c-prune that 
does not have specific interactions with the globular portions of the whole protein begins at 
residue 371 and retains the secondary structure propensities (2 and 3) indicated by the 
NMR analysis, with a more compact C-terminal region (amino acids 410-440)
[41]
. To better 
understand the Nm23-H1/c-prune interaction, a series of two-dimensional [
1
H, 
15
N]-HSQC 
experiments were performed.  
 
 
 
 
Fig.8 Two dimensional 
1
H-
15
N HSQC spectrum of the h-prune C-terminal. (Left) Backbone amide proton 
resonances are narrowly dispersed over the range of 7.8 ppm to 8.8 ppm, which is characteristic of 
unstructured proteins. (Right) Expanded region to allow labeling of the crowded central region of the 
spectrum. 
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Fig.9 The secondary chemical shift index, corrected for sequence-dependent contributions, based on 
1
Hα, 
13
Cβ, 
13
Cα and 
13
CO chemical shifts of the h-prune C-terminal. Protein regions with a propensity to a helical 
structure (α1, α2 and α3) are highlighted. The 1H-15N steady-state heteronuclear NOE values are also 
reported, according to the h-prune C-terminal amino acids.  
 
 
 
 INTRODUCTION 
 
16 
 
 
 
 
 
 
 
 
 
 
Fig. 10. Three-dimensional model of full-length h-prune. A. The amino acids showing large variations 
upon complex formation with Nm23-H1 and the CPP peptide are mapped in cyan. The regions colored in 
magenta correspond to the amino acids recognized exclusively by Nm23-H1, as shown in detail in panels B 
and C.  
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Progressive additions of Nm23-H1 induced line broadening and a strong reduction in the 
peak intensities of some of the amino acids located in the 387-395 region and in the more 
compact region constituted by the disulfide-bridged cycle and the 3 helical region (amino 
acids 410-440). This should therefore represent the Nm23-H1 binding epitope (Fig. 10 
A,B,C)
[41]
.  
These studies have been performed exclusively in vitro and allowed to identify the binding 
site of Nm23-H1 on c-prune surface. In addition further recent studies using a mimetic 
peptide, derived from the minimal interaction region of Nm23-H1 with h-prune, showed 
the impairment of NBL in vivo and elected it as possible therapeutic strategy
[41]
. 
Gene expression studies and protein–protein pull-down analyses coupled to mass 
spectrometry have led to the identification, to date, of three h-prune interacting partners 
that themselves have important features: glycogen synthase kinase-beta (GSK-3), gelsolin 
[43]
 and ASAP1
[47]
. GSK-3 is a serine–threonine kinase[48] that was initially shown to 
phosphorylate and inactivate glycogen synthase
[49]
. GSK-3 is known to be involved in 
energy metabolism, neuronal cell development and body pattern formation
[48]
. Together 
with the strong co-localization of h-prune with the focal adhesions proteins F-actin, 
paxillin and vinculin in several cell types (including breast cancer cell lines), this h-prune–
GSK-3 interaction has led to the hypothesis of a specific association of h-prune with 
microtubule architecture and dynamics
[42-44]
. This would, in turn, results in h-prune 
modulation of the cell-shape processes involved in cell development, proliferation, 
migration and differentiation; all of which are activities that are linked to cancer
[50]
. 
Gelsolin is a member of a family of proteins that can modulate the structural dynamics of 
the actin cytoskeleton, through the sequestration and capping of monomeric G-actin, and 
then severing and capping of the barbed ends of polymerized F-actin filaments
[51]
. Thus  
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gelsolin is involved in the different physiological processes that enable cells to control 
their shape and motility. The formation of the h-prune-gelsolin complex might also include 
the Nm23-H1 protein
[50]
. 
ASAP1 is a multi-domain adaptor protein with ADP-ribosylation factor-GAP activity, as 
being potentially involved in tumor progression. ASAP1 has been implicated in regulating 
cell motility and invasion
[52]
. It is amplified and overexpressed in uveal melanomas and in 
colorectal, prostate and breast carcinomas
[53-56]
. ASAP1 has been functionally linked with 
breast cancer metastasis
[55]
. It was demonstrated that ASAP1 interacts with h-prune
[47]
. 
Furthermore, ASAP1 stimulates the phosphodiesterase activity of h-prune, an activity 
required for its motility-promoting properties
[37]
. To be able to understand the molecular 
details of these interactions would shed light on the complex mechanisms at the base of 
many cancers. 
This PhD project has been focused on the study of the IDD c-prune belonging to a class of 
proteins/domains, whose involvement in many cellular processes is emerging. Indeed, 
many gene sequences in eukaryotic genomes encode entire proteins or large segments of 
proteins that lack a well-structured three-dimensional fold. Disordered regions can be 
highly conserved between species in both composition and sequence and, contrary to the 
traditional view that protein function equates with a stable three-dimensional structure, 
disordered regions are often functional, in ways that we are only beginning to discover. 
Many disordered segments fold on binding to their biological targets (coupled folding and 
binding), whereas others constitute flexible linkers that have a role in the assembly of 
macromolecular arrays
[57]
.  
Many eukaryotic proteins are modular that is, they contain independently folded globular 
domains that are separated by flexible linker regions. Linker sequences vary greatly in 
length and composition, but many are rich in polar, uncharged amino acids (such as Ser, 
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Thr, Gln and Asn), in the small residues Ala and Gly, and in Pro residues. In the absence of 
their targets, modular proteins often behave as “beads on a flexible string”, where the 
function of the linker is, primarily, to enable a relatively unhindered spatial search by the 
attached domains
[58]
. However, binding can induce structure formation in linkers, which 
can have significant functional consequences. The intrinsically disordered proteins (IDPs) 
have a lot of functions that include the regulation of transcription and translation, cellular 
signal transduction, protein phosphorylation, the storage of small molecules, and the 
regulation of the self-assembly of large multiprotein complexes such as the bacterial 
flagellum and the ribosome. A recent review
[58]
 highlights the occurrence of unfolded 
regions in proteins that function as chaperones for other proteins and for RNA molecules, 
and proposes that the unfolded regions work by binding to misfolded proteins and RNA 
molecules
[58]
.  
The aim of this PhD project was to design a suitable system to study a protein in its 
physiological conditions. This methodology becomes more intriguing when the selected 
molecule is an IDP, whose folding may be induced by its interaction with the partners. Our 
target has been the IDD c-prune. Firstly we tried to obtain a fusion protein able to 
introduce c-prune in the cell to perform in cell-NMR spectra. To achieve this goal we have 
studied the mechanism of internalization of this domain in eukaryotic HeLa cell line using 
different CPPs. Successively the behavior of c-prune in cell lysates of eukaryotic cells has 
been evaluated. 
In particular we focused on the use of gH625 for delivery of c-prune. The peculiar 
properties of gH625 render it an optimal candidate to act as a carrier for net acidic charged 
molecules by comparison with the positively charged TAT. Furthermore this study is 
focused also on the interaction studies between c-prune and its different partners over-
expressed in human cells via NMR spectroscopy. Besides Nm23-H1, the interaction with 
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GSK-3, ASAP1 and gelsolin has also been studied. All these proteins are involved in 
different physiological processes that enable cells to control their shape and motility and 
that are strictly linked to tumor progression. 
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EXPERIMENTAL PROCEDURES 
Materials 
Escherichia coli strains DH5α (Invitrogen, California, USA) and BL21 (DE3) STAR 
(Invitrogen, California, USA) were used for cloning and expression of the recombinant 
proteins, respectively. pET28b+ (Novagen, Wisconsin, USA) and pETM11 (EMBL) were 
used as expression vectors. The oligonucleotides were synthesized by Primm (Milano, IT). 
All the other reagents used were from Delchimica (Naples, Italy). The anti-Nm23-H1 
antibody and anti-his antibody were from Sigma Aldrich.  
Cell culture  
HeLa cells (ATCC, USA) SH-SY5Y cells (ATCC, USA) and Human Embryonic Kidney 
cells (HEK-293) were grown in DMEM supplemented with 10% fetal bovine serum (FBS), 
1% glutamine, 100 U/mL penicillin and 100 µg/mL streptomycin (Invitrogen, Carlsbad, 
CA) at 37° C in humidified air with 5% CO2.  
Cloning strategy of gH625-c-prune and TAT-c-prune 
The coding sequence of gH-625-644 (60 bp) was amplified by polymerase chain reaction 
using specific primers from genomic DNA of Herpes simplex virus 1 (HSV-1). To ensure 
correct orientation into the multiple cloning sites of the vector, the forward primer (5’- 
GGAATTCCATATGCACGGCCTCGCCTCG -3’) incorporated a NdeI restriction enzyme 
site, whereas the reverse primer (5’- CATGCCATGGGGAAGGCGCGGATCAG-3’) 
incorporated a NcoI site. The digested fragment was ligated to the gene encoding c-prune 
(amminoacid sequence 353-454, pETM11 c-prune) previously digested with the restriction 
enzymes NcoI and XhoI 
[41]
. The fused segment was finally ligated to the expression vector 
pET28b+ which provided a cleavable N-terminal His6 tag. The coding sequence of TAT-c- 
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prune was obtained through two consecutive PCR reactions. The first PCR reaction was 
carried out using pETM11-c-prune as a template and the forward primer  (5’-
CCGCCAGCGCCGCCGCCCCCTGCTCCAGGAAGC-3’) and  the reverse primer (oligo 
rev454) incorporated XhoI restriction enzyme site (5’-
CCGCTCGAGTTACTTCTTGGACAGGGAGGCTG-3’). The product of this PCR was 
used as template for a second PCR reaction using the forward primer incorporated NcoI  
restriction enzyme site (5’-CATGCCATGG 
GCTACGGCCGCAAGAAACGCCGCCAGCGCCGCC-3’) and the oligo rev454. 
The coding sequence of TAT-c-prune was ligated to the expression vector pETM11 which 
provided a cleavable N-terminal His6 tag. The resulting positive plasmids were used to 
transform E. coli BL21 (DE3) STAR strain. The expression of the recombinant proteins 
(gH625-c-prune and TAT-c-prune) was carried out using the transformed cells grown at 
37°C in 0.5L of LB containing 50 g/mL kanamycin and then inducing them overnight 
with 0.5 mM IPTG at 22 °C. 
Production of recombinant gH625-c-prune and TAT-c-prune 
C-prune was expressed and purified as elsewhere described 
[41]
. The gH625-c-prune and 
TAT-c-prune proteins were purified from inclusion bodies. Briefly, the cells were 
resuspended in 30 mL of 50 mM Tris-HCl (pH 7.5), 8 M urea, 300 Mm NaCl, and 5% 
glycerol (buffer A) and incubated for 16h at RT and then sonicated to promote cell lysis. 
The soluble and insoluble fractions of the lysate were then separated by centrifugation 
(17000 rpm for 20 min at 4 °C). The soluble fraction of the lysate was mixed with 4 mL of 
Ni-NTA resin (Qiagen) equilibrated with the same buffer and then incubated for 1 h at RT. 
The column was washed with ten volumes of denaturing buffer (buffer A) plus 50 mM 
imidazole. The denatured proteins were then eluted by increasing imidazole concentration  
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(300 mM). The purity of the proteins were analyzed by 15% SDS–PAGE whereas their 
concentration was determined by the Bradford assay using BSA as protein standard. The 
refolding procedure was carried out by the dilution of the denatured proteins concentrated 
at 0.2-0.4 mg/mL in 50 mM Tris-HCl (pH 7.5), 300 mM NaCl, 5% glycerol, 0.5M L-
Arginine and 5mM dithiothreitol (DTT). After an overnight mild stirring at 4 °C, the 
insoluble proteins were removed by centrifugation at 12000 rpm for 30 min at 4 °C. To 
remove the His-tags, the refolded proteins were subjected to proteolytic digestion with 
thrombin, for gH625-c-prune and TEV protease for TAT-c-prune, respectively. The 
concentration of the refolded proteins were estimated by Bradford assay. Then, the proteins 
were loaded onto a Superdex 75 gel filtration column (HiLoad 10/30, GE Healthcare) pre-
equilibrated with 50 mM Tris-HCl (pH 7.5), 300 mM NaCl, 5% glycerol, 1.5% D-glucose 
and 5 mM DTT. 
Cloning, expression and purification of c-prune and its mutants 
The construct, pETM-11-c-prune, has been already described elsewhere
[41]
. The single 
mutants, namely L394A, D422A and D388A, were produced by following the protocol 
outlined in the Quick Change II site directed mutagenesis kit (Stratagene). Two 
overlapping complementary primers containing the desired nucleotide changes were 
designed for each mutation using appropriate oligonucleotides. Plasmids carrying the 
above mentioned mutations were sequenced at the Primm DNA sequencing service 
(Naples Facility). The plasmids containing the mutations inserted were used to transform 
BL21 (DE3) STAR competent cells. Protein expression and purification protocols for 
15
N 
labeled c-prune and its mutants have been performed as previously reported with slight 
modifications 
[41]
. Briefly, the transformed BL21 (DE3) STAR cells were grown at 37°C 
on a LB agar plate containing 100 g/mL kanamycin for 16 h. A single colony was picked  
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and grown in 80 mL of a LB medium containing 100 g/mL kanamycin at 37° C 
overnight. To switch from LB medium to a minimal medium, the cells were pelleted at 
3000 rpm for 10 min, then washed by using 10 mL of minimal medium containing 
15
NH4Cl 1 g/L, glucose 2 g/L, Na2HPO4 6 g/L, KH2PO4 3 g/L, NaCl 0,5 g/L, MgSO4 120 
mg/L, thiamine 300 mg/L, CaCl2 11 mg/L and 100 g/mL kanamycin. Bacteria were 
diluted (1:100) into 0,5 L of minimal medium and grown at 37 °C until OD600 ≈ 0.8. 
Protein expression was induced with 0.5 mM IPTG at 22 °C and cells were harvested after 
16 h of incubation. The harvested cells were suspended in 30 ml of a cold buffer 
containing 50 mM Tris-HCl, 300 mM NaCl, pH 7.5 (Buffer A) supplemented with a 
protease inhibitor cocktail (Complete EDTA-FREE, Roche).  The cells were sonicated 10 
minutes (10s on / 10s off). The lysate was centrifuged at 12000 rpm for 30 min  to remove 
cell debris and other particles. The supernatant was loaded on Hi-Trap column (GE 
Healthcare) equilibrated with Buffer A  and eluted with a step of imidazole (500 mM). The 
His-tag was removed by TEV cleavage followed by an additional step of Ni-NTA affinity. 
The purity of c-prune and its mutants was evaluated by using 15% SDS–PAGE. The 
molecular mass was analyzed by ESI-Quadrupole mass spectroscopy. For NMR 
experiments proteins were extensively dialyzed against PBS buffer (pH 7.4). 
Circular dichroism measurements 
CD spectra were recorded with a Jasco J-810 spectropolarimeter equipped with a Peltier 
temperature control system (Model PTC-423-S). Far-UV measurements (195–250 nm) 
were carried out at 20° C in a buffer containing 10 mM Tris-HCl (pH 7.5), NaCl 100mM, 
1.25% glycerol and dithiothreitol (DTT) 1mM using a 0.1 cm optical path length cell and a 
concentration of 40M for gH-625-644 peptide and 8 M for all proteins analysed. CD 
spectra, recorded with a time constant of 4 s, a 2 nm band width, and a scan rate of 10 nm 
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min
−1
, were signal-averaged over at least three scans. The baseline was corrected by 
subtracting the buffer spectrum. Thermal denaturation curves were recorded over the 20–
95 °C temperature interval, following the CD signal at 222 nm. The curve was registered 
using a 0.1 cm path length cell and a scan rate of 1.0 °C min
−1
. 
Western blot analysis  
His-tagged gH625-c-prune (2 mg) was immobilized on Ni-NTA resin. To obtain cellular 
lysates from HeLa cells, they were re-suspended in PBS supplemented with 1% Triton X-
100 and protease inhibitors. After 30 minutes on ice, cells were centrifuged at 12000 rpm 
for 30 minutes. The amount of total proteins present in the extract was determined by 
Bradford assay. Total extract of HeLa cells (4mg of protein) was incubated with the resin 
at 4°C overnight. After extensive washing the elution was carried out with increasing 
imidazole concentration (300mM). The collected fractions were analysed by western 
blotting using an anti-Nm23-H1 antibody and an anti-his antibody as control of 
immobilized protein.  
Preparation of Small Unilamellar Vesicles 
Small Unilamellar Vesicles (SUVs) consisting of DOPC/Chol (1:1) and 25% of Br-PC, 
were prepared according to the extrusion method of Hope et al. 
[59] 
in 5 mM Hepes, 100 
mM NaCl, pH 7.4. Lipids were dried from a chloroform solution under a stream of 
nitrogen-gas and lyophilized overnight. For fluorescence experiments, dry lipid films were 
suspended in buffer by vortexing for 1h and sonicated for 30 min. 
Tryptophan fluorescence experiments  
Br-PC employed as quencher of tryptophan fluorescence is suitable for probing membrane 
insertion of gH625-c-prune, since it acts over a short distance and does not drastically 
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perturb the membrane
[60][61]
. gH625-c-prune, containing the tryptophan residue in the 
peptide sequence, was added (final concentration of 4μM) to 2 ml of buffer (5mM HEPES, 
100mMNaCl pH 7.4) containing 100μM of Br-PC/Chol SUV and a total lipid 
concentration of 400 μM, thus establishing a lipid:peptide molar ratio of 100:1. Emission 
spectrum of the tryptophan was recorded with excitation set at 295nm. SUV composed of 
DOPC/Chol (1/1) and which contained 25% of either 6,7 Br-PC, or 9,10 Br-PC or 11,12 
Br-PC were used. Three separate experiments were conducted for each condition. In 
control experiments,gH625-c-prune in DOPC/Chol (1/1) SUVs without Br-PC was used. 
Labelling of gH625-c-prune and TAT-c-prune 
The gH625-c-prune, TAT-c-prune and c-prune were labeled with N-((2-
(iodoacetoxy)ethyl)-N-Methyl)amino-7-Nitrobenz-2-Oxa-1,3-Diazole (IANBD, 
Invitrogen) a fluorophore that interacts specifically with reduced cysteines. The reaction 
was conducted in a buffer containing 50 mM Tris-HCl (pH 7.5), 300 mM NaCl, 5% 
glycerol, 1.5% D-glucose and 5mM DTT with a 10-fold molar excess of IANBD added as 
a stock solution (10 mg/ml in dimethylformamide) for 4 h at 4°C in slow agitation. The 
excess of IANBD was removed by extensive dialysis at 4°C in the reaction buffer. 
Flow cytometry of cell association of gH625-c-prune 
Cell association was measured by flow cytometry using a FACScan (Becton Dikinson). 
NBD-labelled-gH625-c-prune (5 M) was added to HeLa cells (5 x 105 cells in 0.5 mL) in 
OptiMEM medium at 37°C in slow agitation for 10 min. Thereafter, the cells were washed 
in PBS, 0.1% BSA and then re-suspended in 0.5 mL of PBS, 0.1% BSA for flow 
cytometric analysis. The NBD-labelled-gH625-c-prune was excited at 465 nm and the 
fluorescence was measured at 530 nm. A stock solution of dithionite (1M) was freshly  
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prepared in 1 M Tris-HCl (pH 10). Following flow cytometric analysis, 5L of dithionite 
stock solution was added to cells maintained at 4°C and the fluorescence of internalized 
gH625-c-prune was measured after 5 min.  
Cellular uptake kinetics and endocytosis inhibition of gH625-c-prune and TAT-c-prune 
by confocal microscopy  
For protein uptake-kinetics experiments on non-fixed living cells, 10
5 
HeLa cells were 
incubated with 30 μM of NBD-protein solutions at 37°C for 10 and 30 min. After 
incubation, cells were rinsed twice with PBS and fresh cell culture medium without phenol 
red was added.  
To inhibit the endocytic pathways, HeLa cells were treated with sodium azide, 
cytochalasin D and low temperature. In particular, a 40 μM sodium azide solution was 
added to the cell culture medium for 30 minutes followed by 30 min of incubation with 
proteins. Moreover, to disassemble actin microfilaments, HeLa cells were treated with 30 
µM cytochalasin D in cell culture medium for 30 min at 37 °C before protein incubation. 
After cytochalasin D treatment, cells were incubated with protein solution for 30 min. 
Furthermore, 4° C blocking experiments were carried out by incubating cells with protein 
solutions at 4° C for 30 min.  
All the samples were observed by a confocal laser scanning microscope (CLSM) 
(LSM510, Zeiss) equipped with a 488 nm Argon laser line and with a 63× water-
immersion objective. 
Transfections 
Before transfection, HEK-293 cells were plated and incubated overnight at 37°C. The 
following day, immediately prior to transfection, medium was changed. Transfections were  
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achieved using calcium phosphate according to the protocol. 60% confluent HEK-293 
were transfected with 15 g of DNA per 10-cm dish, using vectors encoding HA-
NM23H1, HA-NM23H1-P96S and HA-NM23H1-S120G, each mutant was created as 
described by Reymond A. et al. 
[46]
. The cells were collected 48 h later the transfection 
assays and the lysates were obtained as described above.  
NMR sample preparation 
NMR samples were prepared mixing 
15
N-labeled stock solution of c-prune and its mutants 
(100 M final concentration) with cell extracts (2 mg of total protein) in a final volume of 
500 L supplemented with 10% D2O. By this procedure, the overall extract dilution factor 
was kept constant and uniformly small (20%). To prevent c-prune degradation, protease 
inhibitors were added 
NMR measurements and analysis 
All experiments were recorded on a Varian INOVA 600-MHz NMR spectrometer 
equipped with a cold-probe and at room temperature. 2D [1H-15N] heteronuclear single 
quantum coherence (HSQC) correlation spectra were acquired by using a fast version of 
sensitivity enhanced HSQC pulse-sequence. Lysate data were recorded with 16 transients 
and 1024 (
1
H) x 64 (
15
N) complex points. The reference experiments of pure samples in 
NMR buffer were obtained with identical spectrometer settings. NMR peaks parameters, 
like signal intensities, background noise and chemical shift values, were independently 
extracted and analyzed with Neasy, a tool of CARA software. Intensity ratios were 
computed as Int(buffer)/Int(lysates) and Int(lysates)/Int(lysates overexpressing c-prune 
partners).  
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RESULTS 
Cloning and expression of gH625-c-prune and TAT-c-prune 
In order to obtain a protein able to enter into cells and to study it in its physiological 
conditions, we designed two constructs containing c-prune fused with two different 
peptides for cellular internalization, gH625-644 and TAT. The coding sequence of gH625-
644 (60 bp) was amplified by polymerase chain reaction using specific primers for 
genomic DNA of Herpes simplex virus 1 (HSV-1). The digested fragment was ligated to 
the gene encoding c-prune. The fused segment was finally inserted into the expression 
vector pET28b+ which provided a cleavable N-terminal His6 tag.  
The coding sequence of TAT was fused to c-prune cDNA sequence performing two 
consecutive PCR reactions as describe in the experimental section. The coding sequence of 
TAT-c-prune was inserted into the expression vector pETM11 which provided a cleavable 
N-terminal His6 tag. The recombinant clones of both constructs obtained were sequenced 
by Primm sequencing service. Different cell strains and environmental conditions 
(temperature and IPTG concentrations) were tested to optimize the expression of the 
recombinant proteins. The best level of expression were achieved using E. coli BL21 
STAR (DE3) cells grown at 37 °C and induced overnight with 0.5 mM IPTG at 22 °C. 
Purification of gH625-c-prune and TAT-c-prune 
Recombinant gH625-c-prune and TAT-c-prune were purified from inclusion bodies using 
a nickel affinity chromatography in denaturing conditions. The collected fractions were 
subjected to a refolding process via direct dilution to prevent aggregation and precipitation 
of the protein. The refolded proteins were subjected to proteolytic digestion with thrombin 
(gH625-c-prune) and TEV protease (TAT-c-prune), in the optimized conditions, to remove 
the His-tag with an efficiency of about 60%. The digested sample was loaded onto a  
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Superdex  75  gel  filtration  column  pre-equilibrated  with  an  appropriate  buffer  (see  
Experimental Procedures) to separate the protein aggregates from the properly folded 
forms. The purity of the proteins were assessed by SDS-PAGE (Fig. 11). Since gH625-c-
prune and TAT-c-prune have shown the tendency to aggregate during their concentration it 
was not possible to concentrate them over 30 M. 
 
Fig. 11 Electrophoretic analysis carried out on 15% SDS-PAGE.  Tat-c-prune (1), gh625-c-prune (2), and 
c-prune (3) purified to homogeneity. 
 
Circular dichroism measurements 
The secondary structure of gH625-c-prune, TAT-c-prune, c-prune and gH625-644 peptide 
was determined by CD spectroscopy in the far UV spectral region (195–260 nm). CD 
spectra show that gH-625-c-prune protein has a degree of structure in solution which was 
absent in the protein alone and in the peptide alone. In fact, circular dichroism studies 
performed on c-prune
[41]
, TAT-c-prune and on gH625-644 peptide highlight the lack of 
any structure (Fig 12A). Instead, the CD spectrum of the  recombinant protein gH625-c-
prune, in the same conditions, is characterized by the presence of two minima (at 208 and 
222 nm) and one maximum (at 195 nm) which are typical fingerprints of α/β proteins (Fig 
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12A). The thermal denaturation curve of gH625-prune presents a sigmoidal shape with a 
single inflection point, corresponding to Td values of about 52 °C (Fig. 12B). 
 
 
Analysis of gH625-c-prune biological function 
To verify if c-prune retained its biological activity after conjugation with the peptide 
gH625, we verified the complex formation with Nm23-H1 by western blotting
[41]
. His 
tagged gH-625-c-prune was immobilized on the resin and total extract of HeLa cells was 
loaded onto it (see experimental procedures). The western blotting analysis showed that 
gH-625-c-prune is still able to interact with Nm23-H1 in HeLa extract (Fig. 13), 
suggesting that the folding of the protein does not affect its biological function.  
 
 
 
 
Fig. 12Far-UV CD spectra. A) Far-UV CD spectra of gh625-c-prune (solid line), tat-c-prune (dashed  
line), c-prune (dotted line) and gH625-644 (dashed-dotted line) in 10mM Tris-HCl (pH 7.5), NaCl 100mM, 
5% glycerol and dithiothreitol (DTT) 1mM. The spectra were recorded using 0.1 cm path length cells. The 
protein and peptide concentration were 8 M and 40 M, respectively. B) Temperature-induced 
denaturation curves of gH625-c-prune obtained by recording the molar ellipticity at 222 nm in 10 mM 
Tris-HCl (pH 7.5), 100 mM NaCl, 5% (v/v) glycerol and DTT 1mM. 
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Fluorescence measurements 
A tryptophan residue naturally present in the sequence of a protein or a peptide can serve 
as an intrinsic probe for the localization of the peptide within a membrane; in fact, the 
fluorescence emission of a tryptophan residue increases when the amino acid enters a more 
hydrophobic environment, and together with an increase in quantum yield, the maximal 
spectral position will be shifted toward shorter wavelengths (blue shift). The peptide 
gH625 contains a tryptophan residue in the middle of the sequence; Fig. 14 shows the 
fluorescence emission spectra of the peptides gH625 upon interaction with Br-DOPC/Chol 
vesicles. In this experiment the gH625-prune location inside the bilayer was investigated 
by measuring the relative quenching of the gH625 Trp fluorescence by the probes 11,12- 
Br-PC, 9,10-Br-PC and 6,7-Br-PC, which differ in the position of the quencher moiety 
along the hydrocarbon chain and allow to establish the depth of the peptide insertion into 
the membrane. For all the probes used, it is evident a quench of the Trp emission. These 
Fig. 13 Western blotting analysis of gH-625-c-prune biological function. Lane A1: His tagged gH-625-c-
prune. Lane H: HeLa total extract. Lane L1 wash with 50mM imidazole. Lane L2: wash with 50mM 
imidazole of resin without gh625-c-prune immobilized. Lane M: molecular weight markers. Lane E1: elution 
with 300mM imidazole. 
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results indicate that, upon binding to vesicles, the peptide is deeply inserted into the 
membrane bilayer. 
 
Determination of NBD-gH625-c-prune cellular uptake 
We have determined the fraction of NBD-labeled gH625-c-prune taken up into HeLa cells 
by flow cytometry. This fraction is determined by comparing the fluorescence intensity 
before and after addition of sodium dithionite, an essentially membrane-impermeant 
molecule, which suppresses irreversibly the fluorescence of the accessible NBD-moiety 
localized on the external cell surface. We incubated NBD-gH625-c-prune () with 
HeLa cells at 37°C. After 10 min of incubation, we measured the quenching of the NBD-
gH625-c-prune by dithionite treatment. The dithionite reaction was performed at low 
temperature (4 °C) because the dithionite diffusion in the biological membranes is strongly 
Fig. 14 Tryptophan fluorescence emission spectra. Tryptophan fluorescence emission spectra of the 
gH625-c-prune upon interaction with Br-DOPC/Chol vesicles. gH625-c-prune incubated with SUV (solid 
line), with SUV which contained 6,7 Br-PC (dashed line), with SUV which contained 9,10 Br-PC (dotted 
line) and with SUV which contained 11,12 Br-PC (dashed-dotted line). 
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reduced in comparison with high temperatures
[62]
. After the addition of dithionite there is 
an increase of fluorescence compared to the intrinsic fluorescence of the cells (Fig.15).  
 
This shows that a percentage of protein (ca. 50%) has been internalized in 10 min. 
Increasing protein concentration, time of incubation or dithionite concentration did not 
result in an increase of yield’s internalization. NBD was used in the same experiment to  
exclude that the fluorescence signal was due to internalization of the fluorophore alone and 
no cellular fluorescence was observed at concentration up to 15 M (data not shown). 
 
Uptake kinetics and endocytosis inhibition 
To verify if gH625 peptide could promote c-prune internalization, we examined uptake in 
Hela cells by confocal microscopy. We incubated 30 μM gH625-c-prune solution in cell 
culture medium for 10 and 30 min at 37°C. Images show a fluorescence signal in HeLa 
cells already after 10 min incubation for gH625-c-prune (Fig. 16A). Moreover, by 
increasing incubation time, the intracellular fluorescence intensity increased (Fig. 16C). 
Fig. 15 Flow cytometric analysis of Hela cells treated with NBD-gh625-c-prune. Cells are treated for 10 
min with 5 M NBD-gh625-c-prune in the presence or absence of dithionite. Not treated cells (solid line), 
treated with NBD-gh625-c-prune (dashed line), treated with NBD-gh625-c-prune and dithionite (dotted line). 
Single result representative of three similar experiments. 
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Conversely, no fluorescence was observed in case of c-prune (Fig. 16 I and K) and only a 
slight intracellular fluorescence was detectable after incubation with TAT-c-prune (Fig. 16 
E and G). gH625-c-prune uptake was partially due to endocytic mechanisms as 
demonstrated by endocytosis inhibition experiments. In particular, gH625-c-prune uptake 
was significantly inhibited by NaN3 and 4 °C treatments (Fig.17 C and G). In addition, 
80% uptake inhibition was observed after incubation with cytochalasin D (Fig. 17 E). 
These data demonstrate that gH625-c-prune internalization significantly depends on active, 
ATP dependent mechanisms and suggest that there is a small amount of gH625-c-prune 
that use a different, probably passive, mechanism to cross cell membrane. 
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Fig. 16 Uptake kinetics. Uptake kinetics of HeLa cells incubated at 37°C with gh625-c-prune (A-D), TAT-c-prune 
(E-H) and c-prune (I-L) for 10 (left panels) and 30 (right panels) min. Fluorescence (A, C, E, G, I and K) and 
transmitted light (B, D, F, H, J and L) images. Magnification bar: 20 µm. 
Fig. 17 Uptake inhibition experiments. Confocal laser scanning microscope images of HeLa cells incubated with 
gh625-c-prune protein at 37°C (A and B), NaN3 (C and D), cytochalasin D (E and F) at 4°C (G and H). 
Fluorescence (A, C, E and G) and transmitted light (B, D, F and H) images. I. Percentage of uptake as a function of 
inhibition treatments. Magnification bar: 20 µm. 
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h-prune/Nm23-H1 interaction in unlabeled lysates. 
Due to the low concentration of recombinant gH625-c-prune samples obtained a new route 
has been undertaken. We performed some NMR experiments by using eukaryotic cellular 
extracts which potentially provide further information about the binding mode of these 
proteins close to physiological conditions. Therefore, we began our cellular analyses by 
adding labeled c-prune to HEK-293 lysates. Despite the high abundance of endogenous, 
unlabeled proteins, the resulting 2D [15N, 1H] HSQC spectra of c-prune in HEK-293 lysates 
were superimposable with the reference spectra of the protein in buffer solution (Fig. 18), 
confirming that c-prune retains the same conformation in cellular environment and does 
not interact with any of the endogenous components in the lysate. However the average c-
prune amide resonance signal intensity in the HEK-293 lysate was notably reduced with an 
overall increase in proton line-widths correlating well with the expected increase in the 
protein total correlation time (τc) due to cellular viscosity[12]. To investigate the specific 
association between c-prune and Nm23-H1 as much as possible closest to physiological 
conditions, a starting solution of purified 
15
N-labeled c-prune was added to HEK-293 
lysate overexpressing Nm23-H1 (Fig. 19). 
The appearance of some dispersed peaks, together with the disappearance or the decrease 
in intensity of several signals in the c-prune [15N, 1H] HSQC spectrum, indicate that the 
protein in the presence of HEK-293 lysates is able to form a specific complex with Nm23-
H1, in agreement with the results observed in previous experiments in vitro
[41]
. 
In effect, we have demonstrated that the Nm23-H1 binding epitope on c-prune surface is 
located in the region encompassing amino acids from 388 to 404 and in the more compact 
region constituted by the disulfide-bridged cycle and the α3 helical region (amino acids 
412-445), as showed in Fig. 20 A-B-C.  
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To further confirm the specific interaction of c-prune/Nm23-H1, the NMR binding 
experiments were repeated by using human NBL SH-SY5Y lysates expressing high levels 
of Nm23-H1. As showed in Fig. 21, SH-SY5Y extracts confirmed that, upon the complex 
formation, Nm23-H1 retains the binding to the two regions (from L387 to D401 and from 
N413 to E444) on the surface of c-prune. 
 
 
 
 
 
 
 
Fig. 18  Overlay of the 2D [
15
N, 
1
H] HSQC correlation spectra of purified c-prune in NMR buffer solution 
(in red) and of c-prune in HEK-293 lysate (in blue). 
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Fig. 19 Overlay of the 2D [
15
N, 
1
H] HSQC correlation spectra of purified c-prune in HEK-293 lysate  (in 
red) and of c-prune in HEK-293 lysate overexpressing Nm23-H1 (in blue). 
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Fig. 20 A) Intensity ratios for all c-prune residues extracted from 2D [
15
N, 
1
H] HSQC experiments 
performed in HEK-293 lysate overexpressing Nm23-H1. B) Intensity ratios for all c-prune residues extracted 
from 2D [
15
N, 
1
H] HSQC experiments in vitro using recombinant Nm23-H1. C) The amino acids showing 
large variations upon complex formation with Nm23-H1 (I0-I/I0≥0.41) are mapped in cyan onto the h-prune 
surface. The region highlighted in red correspond to the polyproline sequence while the region coloured in 
yellow correspond to disulphide bridge between Cys419 and Cys437. 
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Fig. 21 Intensity ratios for all c-prune residues (I0-I/I0≥0.36) extracted from 2D [
15
N, 
1
H] HSQC experiments 
performed in SH-SY5Y lysate (in blue) and compared to the data obtained in HEK-293 lysate (in red).   
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Following the NMR mapping interaction epitopes for c-prune, we used site-directed 
mutagenesis to further validate the binding site for Nm23-H1. Because negatively charged 
amino acids are thought to contribute to the c-prune/Nm23-H1 complex, we aimed to 
disrupt the interaction by uniformly replacing residues D388 and D422 with alanine; 
therefore, these two protein mutants, named D388A and D422A, were produced, purified 
and characterized. Earlier functional studies indicated that both h-prune mutants did not 
induce cell migration and that the mutants interacted weakly with Nm23-H1
[41]
. To 
validate the experimental functional studies we investigated the binding of the two c-prune 
mutants to Nm23-H1 by adding HEK-293 lysates overexpressing Nm23-H1 to a starting 
solution of 
15
N-labeled D388A or 
15
N-labeled D422A. Effectively, D388A and D422A did 
not show a significant change in peak intensities despite c-prune wild type, as indicated in 
the Figure 22 (for D388A) and Figure 23 (for D422A), confirming that just a single point 
mutation on the c-prune binding epitope greatly compromised its ability to interact with the 
Nm23-H1 in vivo. 
Guided by the NMR interaction analysis (Figure 20 C), we designed another c-prune single 
point mutation affecting the Nm23-H1 binding site. In particular, we mutated L394 in 
alanine to evaluate whether uncharged residues also contribute to the complex formation.  
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Fig. 22 Intensity ratios for all c-prune residues extracted from 2D [
15
N, 
1
H] HSQC experiments (in red) 
compared to the data of c-prune (D388A) (in green) performed in HEK-293 lysate overexpressing Nm23-H1. 
 
 
Fig. 23 Intensity ratios for all c-prune residues extracted from 2D [
15
N, 
1
H] HSQC experiments (in red) 
compared to the data of c-prune (D422A) (in green) performed in HEK-293 lysate overexpressing Nm23-H1. 
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NMR binding experiments of the 
15
N-labeled L394A mutant in HEK-293 lysate show 
features of a remnant, substantially reduced interaction (Fig. 24 A & B).  
To further validate our system we used cellular lysates transfected with two well 
characterized single point-mutants of Nm23-H1, P96S and S120G, both known to alter 
Nm23-H1 biochemical activity or structure affecting the cell motility. When oligomeric 
patterns of the recombinant Nm23-H1 proteins were examined by SDS–PAGE after cross-
linking the protein, most oligomers in wild type Nm23-H1 were found to be hexamers, and 
dimers were less than 20% in the wild type. In contrast, no hexamers were found in P96S 
and S120G mutant Nm23-H1 proteins, and much higher proportions of dimers and 
monomers were observed in these mutant proteins compared to the wild type. The 
alteration in the oligomeric structure of Nm23-H1 protein by P96S and S120G mutations 
was also observed in gel filtration chromatography, in which most of the P96S and S120G 
mutant proteins eluted at a position corresponding to the molecular size of dimeric form, 
while a major protein peak in the wild type was detected at an elution volume similar to 
hexameric form. The altered oligomeric structure observed only in P96S and S120G 
mutant proteins suggests the intriguing hypothesis that the oligomeric structure of Nm23-
H1 may be functionally linked to its metastasis suppressing activity. Reduction or loss of 
hexamers in Nm23-H1 by the mutations such as P96S and S120G could result in increased 
metastatic potential of cancer cells. P96S and S120G mutant proteins incapable of motility 
suppression exhibited reduced histidine protein kinase activity and autophosphorylation 
level, respectively. Since reduction of autophosphorylation level reflects decreased 
phosphoenzyme intermediate formation that is involved in histidine protein kinase activity 
as well as NDP kinase activity, these observations imply the fact that those mutations 
reducing histidine protein kinase activity of Nm23-H1, result in suppressive capacity on 
metastatic phenotypes 
[63]
. We resuspended
15
N labeled c-prune in HEK-293 extracts over  
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expressing each Nm23-H1 mutant. The signal intensities of the Nm23-H1 S120G/P96S 
extracts were comparable to those observed in the corresponding extracts not over-
expressing Nm23-H1 (Fig. 25), demonstrating that a single mutation of Nm23-H1 can 
affect the interaction with c-prune. 
 
 
 
Fig. 24 A) Intensity ratios for all c-prune (L394A) residues extracted from 2D [
15
N, 
1
H] HSQC experiments 
(in green) compared to the data of c-prune wild type (in red) performed in HEK-293 lysate overexpressing 
Nm23-H1 and to the data of c-prune/Nm23-H1 interaction in vitro (in blue). B) Overlay of the 2D [
15
N, 
1
H] 
HSQC correlation spectra of purified c-prune (L394A) in HEK293 lysate (in red) and of c-prune (L394A) in 
HEK-293 lysate overexpressing Nm23-H1 (in blue). In table regions of interaction identified for each 
experiment. 
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Fig. 25 Intensity ratios for all c-prune residues extracted from 2D [
15
N, 
1
H] HSQC experiments performed in 
HEK-293 lysate overexpressing Nm23-H1 (S120G) up and Nm23-H1 (P96S) down.  
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h-prune interactions with GSK3beta and gelsolin in unlabeled lysates 
Moreover, we extended functional studies in cell lysates to other h-prune endogenous 
partners, such as GSK3, gelsolin and ASAP1. Upon addition of HEK-293 extracts over-
expressing GSK3or gelsolin or ASAP1to starting solutions of 15N labeled c-prune the 
NMR peaks weakened, indicating c-prune interaction with each of the proteins. In 
particular, residues between Q356 and S396 and residues from A361 to R389 of the 
15
N 
labeled c-prune show an extensive line broadening in the presence of HEK-293 lysate 
overexpressing GSK3 and gelsolin, respectively (Fig. 26 A & B). Interestingly, in cell 
lysate NMR experiments outline GSK3 and gelsolin binding sites that lie on the N-
terminal portion of c-prune, indicating a remarkable binding versatility of this domain, 
likely due mostly to its intrinsically disordered nature. Indeed, residues 353-365 of c-prune 
constitutes the C-terminal region of h-prune DHHA2 domain and thus GSK3 and gelsolin 
interaction also with this domain cannot be excluded. On the other hand, in the presence of 
cellular extract overexpressing ASAP1 no changes in signal intensities in the c-prune [
15
N, 
1
H] HSQC spectrum were observed corroborating the hypothesis that this partner does not 
interact with the C-terminal domain of h-prune but, probably, with the other two domains, 
DHH and DHHA2, involved in the catalytical activity and therefore able to stimulate h-
prune phosphodiesterase activity. (Fig. 27 A & B)
[47]
. 
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Fig. 26 A) Intensity ratios for all c-prune residues (I0-I/I0≥0.32) extracted from 2D [
15
N, 
1
H] HSQC 
experiments performed in HEK-293 lysate overexpressing GSK-3. The amino acids showing large 
variations upon complex formation with GSK-3are mapped in magenta onto the h-prune surface. B) 
Intensity ratios for all c-prune residues (I0-I/I0≥0.21) extracted from 2D [
15
N, 
1
H]  HSQC experiments 
performed in HEK-293 lysate overexpressing Gelsolin. The amino acids showing large variations upon 
complex formation with gelsolin are mapped in orange onto the h-prune surface. The region of h-prune 
coloured in red correspond to the polyproline sequence.  
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Fig. 27 A) Intensity ratios for all c-prune residues (I0-I/I0<0.36) extracted from 2D [
15
N, 
1
H] HSQC 
experiments performed in HEK-293 lysate overexpressing ASAP1. B) Model of interaction between ASAP1 
and h-prune. 
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DISCUSSION 
The aim of this PhD thesis was to design an appropriate system to study a protein in its 
physiological conditions. This methodology becomes more intriguing when the selected 
molecule is c-prune, a domain belonging to the family of Intrinsically Disordered Domain 
(IDD), whose folding may be induced by its interaction with the partners. We tried to 
obtain a fusion protein able to introduce c-prune in the cell to perform in cell-NMR 
spectra. For this purpose we have studied the mechanism of internalization of this domain 
in eukaryotic HeLa cell line using different CPPs. In particular, we focused on a peptide 
derived from Herpes Virus Simplex type 1, gH625. The peculiar properties of this peptide, 
encompassing 625-644 residues of the glycoprotein H (gH) of Herpes simplex virus type 1 
[24]
, render it an optimal candidate to act as a transporter for net acidic charged molecules 
by comparison with the positively charged TAT. Recent studies indicated also that gH625 
cellular uptake is associated with its ability to interact with membrane lipids and to form a 
transient helical structure that temporarily affects membrane organization, thereby 
facilitating insertion into the membrane and translocation bypassing the endocytotic 
pathway
[29]
. Structural studies highlighted that when gH625 is in helical conformation, the 
polar residues concentrate on one face of the helix, giving it an amphiphilic character 
common to fusion peptides of most fusion glycoproteins of class I enveloped viruses. In 
addition gH625 has been used to efficiently deliver in cell quantum dots, that do not 
significantly traverse the membrane bilayer on their own
[30]
; liposomes
[31]
; dendrimers
[14]
; 
or nanoparticles through the blood-brain barrier
[15]
. 
Therefore, gH625 can be considered a promising tool to efficiently perform intracellular 
delivery and may represent an alternative strategy to the use of the well characterized 
positively charged TAT peptide.  
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In this study, we report the validation of gH625 as carrier of c-prune. We designed, cloned, 
expressed and purified the recombinant gH625-c-prune as a soluble product. Far-UV CD 
spectra revealed an unexpected alfa/beta structure of the protein when compared with the 
CD spectra of gH625 or c-prune alone, both typical of unfolded species. In spite of this 
change in structure, gH625-c-prune retained its activity binding to its partner Nm23-H1 as 
verified by Western blot analyses. The quenching of tryptophan fluorescence by 
brominated phospholipid probed the membrane insertion of gH625-c-prune indicating that 
the protein bound to the peptide is located inside the membrane bilayer. This experiments 
may indicate that in the cell, gH625-prune may be able to cross the cell membrane. In 
addition flow cytometric analyses revealed a significant signal of fluorescence 
corresponding to the internalization of gH625-c-prune NBD-labeled, confirmed by the 
quenching of external fluorescence following dithionite treatment. Finally confocal 
microscopy data performed on gH625-c-prune showed that gH625 is able to deliver c-
prune in cells . Data obtained with different inhibitors showed that the entrance in the cell 
is strongly dependent on endocytotic pathway although a fraction of the protein is able to 
cross the bilayer through a translocation mechanism, hypothesized to be the main crossing 
system used by the peptide gH625. It is worth mentioning that not only this is the first time 
that gH625 was shown to be able to deliver intracellularly a protein but this is also the first 
time that an intrinsically disordered protein was shown to be easily transported across the 
membrane bilayer retaining its biological activity.  
In comparison with gH625-c-prune we started a characterization also of TAT-c-prune. The 
typical negative charge of a IDD
[64]
, such as c-prune, could represent a problem to obtain a 
fusion construct with TAT CPP. Indeed TAT-c-prune has been obtained as an unstable 
product in comparison with the stable gH625-c-prune achieving rather high levels of yield. 
Furthermore CD analyses of TAT-c-prune showed a spectrum typical of an unstructured 
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protein. In addition confocal microscopy data performed at the same concentration and 
incubation time for both proteins, gH625-c-prune and TAT-c prune, revealed that only 
gH625 plays a role for c-prune delivery. We can hypothesize that the folding of gH625-c-
prune, as monitored by CD, can represent an improvement and so facilitate the insertion 
into the membrane and subsequent translocation of the protein.  
There is a natural abundance of intrinsically disordered proteins involved in the 
pathogenesis of numerous human diseases which may suggest that in the future these 
proteins may represent a huge reservoirs of novel drug targets. A key role is thus played by 
the availability of delivery tools for IDP. Altogether our results open a wider scenario on 
the potential applications of this membranotropic peptide fused with an IDP.  
Due to the tendency to aggregate, it has not been possible to obtain gh625-c-prune at the 
concentration levels required to perform in cell-NMR experiments. Then, to overcome this 
problem, it was thought to use the NMR in lysates of eukaryotic cells in which is possible 
to use labeled recombinant c-prune. In this way it was feasible to study in detail the c-
prune interactors in physiological environment.  
So, in this PhD thesis we performed the NMR mapping of the c-prune functional sites, 
involved in the interactions with endogenous partners in human cell lysates. By the use of 
total extract of cells overexpressing proteins of interest, either naturally or transfected, we 
could map c-prune epitopes of key interactions with Nm23-H1, GSK-3beta and gelsolin, 
which are involved in relevant pathological cellular pathways. Furthermore, by site-
directed mutagenesis we could identify residues involved in the molecular interactions 
whose mutation prevent the complex formation. Interestingly, the NMR analysis shows 
that the intrinsically disordered third domain of h-prune retains its conformational 
preferences in a cellular environment, at the same time showing a valuable capacity to 
recognize different cellular partners by means of appropriate protein portions. Overall, this 
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study shows that protein functions mediated by protein-protein interactions can be 
accurately followed by in cell lysates NMR fast experiments, which could be easily used 
for a very efficient NMR drug discovery strategy, either starting from fragments or 
developed ligands 
[65-68]
. Finally, this functional characterization contributes to a better 
understanding of the h-prune biological activity and, moreover, by the means of NMR 
technique in cells lysates, it allows to study a protein under physiological conditions 
paving the way for drug discovery studies in intracellular environment. 
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